Global vaccine output remains highly concentrated among a few major producers. Here’s a snapshot of the latest estimates: (Note: Many companies do not publish per‑vaccine production figures; numbers marked with “~” are...
After years of disappointments, the C. difficile vaccine field is quietly repositioning itself. While GSK has officially dropped its own toxoid candidate from the pipeline, at least two other toxin‑based approaches—one...
Download Infographic Overview An adverse event (AE) is any medical event occurring after vaccination, regardless of whether it is causally related. A side effect is a medical event that is confirmed to be caused by a...
Introduction When it comes to vaccines and vaccination, nothing worries patients more than potential side effects. The fear that vaccination could lead to death or disability dates back to the time of Jenner and has...
The processes around vaccine licensure today are still built on a shared core: robust evidence for quality, safety, and efficacy, demonstrated through standardized preclinical testing, phased clinical trials, and...
Europe kicked off 2026 by adding more brains to the vaccine bureaucracy, designating a new WHO Collaborating Centre to help NITAGs turn messy evidence into cleaner policy decisions. In theory, this means fewer hand‑wavy...
Evidence from leading journals since 2021 consistently documents both pronounced vaccine inequity between countries and substantial within‑country access gaps, especially for COVID‑19 but also for routine childhood...
Download Infographic Overview Vaccines contain active ingredients (antigens; mRNA) and inactive ingredients such as stabilizers, antimicrobials, inactivating agents, antibiotics, and residues from the production...